ShareValue scores for 002424.SHE: Valuation 61, Quality 36, Growth 23, Health 48.

002424.SHE
SZSE

Guizhou Bailing Group Pharmaceutical Co Ltd

CN¥4.59(+1.32%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

5% to 16%
Valuation
61
Fair Value
Price vs Value
Quality
36
Weak
Business Strength
Growth
23
Weak
Revenue & Earnings
Health
48
Moderate
Financial Stability
Momentum
33
Bearish
Price Trend

Company Details

About

Guizhou Bailing Group Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells medicines in China. It operates through four segments: Industrial, Commerce, Medical institutions, and Others The company offers medicines in various forms, including tablets, capsules, granules, syrups, powders, pills, dews, pastes, sprays, and oral liquids, as well as wines and honey. Its products are used for cardiovascular, cough, cold, gynecological, and pediatric areas. The company was incorporated in 1999 and is headquartered in Anshun, China.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026